Balaji Amines Q1 Revenue Hits ₹4.56 Billion as Profit Reaches ₹749M

SOLAPUR — Chemical manufacturing major Balaji Amines Ltd reported a consolidated revenue from operations of ₹4.56 billion for the first quarter ending June 30. During the same quarterly period, the Solapur-headquartered specialty chemical producer recorded a consolidated net profit of ₹749.4 million (₹74.94 crore). The financial results highlight stable commercial execution across the company's aliphatic amines, amine derivatives, and specialty chemical verticals serving domestic pharmaceutical, agrochemical, and industrial formulation sectors.

Operational Trajectory and Product Segment Drivers

The June-quarter earnings demonstrate Balaji Amines Ltd's core positioning as one of India's leading manufacturers of methylamines, ethylamines, and specialty chemical derivatives.

The company's primary manufacturing units in Solapur, Maharashtra, alongside subsidiary facilities under Balaji Specialty Chemicals Limited, maintained baseline production throughput. Demand remained steady from active pharmaceutical ingredient (API) manufacturers and crop protection formulation companies, which rely on amine-based intermediates as key building blocks.

In recent quarters, the chemical manufacturing sector has managed raw material pricing adjustments, particularly for methanol and ammonia inputs. Balaji Amines' backward integration and diversified product offerings helped absorb supply chain price fluctuations while maintaining operating margin stability.

Sector Context and Strategic Expansion

India's specialty chemical industry continues to benefit from China-plus-one procurement trends among global pharmaceutical and industrial buyers.

For equity investors, supply chain partners, and chemical market analysts, Balaji Amines Ltd's quarterly performance reflects operational durability. Market participants closely monitor the commercial commissioning of new production capacity, including expanded unit lines for Dimethylformamide (DMF), Acetonitrile, and electronic-grade chemicals designed to import-substitute key manufacturing inputs.

Official Sources

According to official regulatory filings submitted to the National Stock Exchange of India (NSE) and the BSE Limited, the consolidated quarterly financial statements were reviewed by the audit committee and formally approved by the Board of Directors. Corporate releases and operational updates were filed in full compliance with statutory listing regulations.

Official Statement

"According to officials, the company remains focused on optimizing plant capacity utilization across core amine plants, expanding specialty derivative portfolios, and progressing with key capital expenditure programs to support long-term commercial growth."

Why It Matters

The June-quarter metrics offer clear visibility into intermediate chemical consumption across Indian active pharmaceutical ingredient and crop care manufacturing sectors. Generating ₹4.56 billion in revenue alongside ₹749.4 million in net profit demonstrates established market share, providing institutional investors and industrial clients with evidence of supply chain continuity.

Key Facts at a Glance

• Consolidated Revenue from Operations: ₹4.56 billion (₹456 crore) for the June quarter.

• Consolidated Net Profit: ₹749.4 million (₹74.94 crore) for the period.

• Core Product Portfolio: Aliphatic amines, methylamines, ethylamines, and specialty derivative solvents.

• Primary End-User Markets: Pharmaceuticals (API synthesis), agrochemicals, water treatment, and industrial formulations.

Frequently Asked Questions (FAQ)

What was Balaji Amines Ltd's consolidated revenue for the June quarter?

Balaji Amines Ltd reported a consolidated revenue from operations of ₹4.56 billion for the June quarter.

What was the consolidated net profit achieved by Balaji Amines Ltd?

The company posted a consolidated net profit of ₹749.4 million (₹74.94 crore) during the quarterly period.

What products are manufactured by Balaji Amines Ltd?

The company specializes in manufacturing aliphatic amines, methylamines, ethylamines, derivative solvents such as DMF and Acetonitrile, and specialty chemicals.

Where can investors verify official financial filings for Balaji Amines Ltd?

Official regulatory disclosures and financial submissions are available on the National Stock Exchange of India (NSE), BSE Limited, and the Balaji Amines Official Portal.

Source: Official regulatory disclosures filed with the National Stock Exchange of India, BSE Limited, Department of Chemicals and Petrochemicals, and corporate disclosures from Balaji Amines Official Portal.